Search results
Beyond Weight Loss: Semaglutide Delivers Major Heart Health Benefits
SciTechDaily· 12 hours agoWeight Loss Drug Linked With Reduced Need for Diuretics in Heart Failure Patients Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical ...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 hours agoEleven of those 12 cases were in trial subjects treated with aficamten, rather than the placebo. That might be a issue in investors’ eyes, Syed says,...
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
FierceBiotech· 12 hours agoHaving reported primary endpoint success in December 2023, the biotech rolled into the European...
How an 11¢ Twist Can Help You Walk Off Weight Faster, According to Experts
Woman's World via Yahoo News· 7 hours agoTurns out, toasty-sweet turmeric contains an active compound called curcumin that gives it powers...
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 hours agoINmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript May 11, 2024 INmune Bio, Inc. isn’t...
Wegovy Can Help Heart Failure Patients Reduce Meds: Study
US News & World Report· 12 hours agoAfter a year taking Wegovy, "there was evidence of a significant reduction in average loop diuretic dose, a lower likelihood of diuretic treatment escalation, and a greater likelihood of diuretic ...
Duran Duran and Blondie Bring the Rapture to Cruel World Festival
Variety via AOL· 7 hours agoIn the end, the weekend’s solar storm didn’t end up shorting out this year’s Cruel World festival at...
Clinical trial: New drug makes exercise, everyday tasks easier for people with common heart...
Medical Xpress· 23 minutes agoPeople with a common heart condition were able to use significantly more oxygen while exercising...
Do Antipsychotic Overprescribing Warning Letters Work?
Medscape· 20 hours agoWarning letters to primary care physicians (PCPs) regarding overprescription of quetiapine were...
Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
Pharmaceutical Technology via Yahoo Finance· 10 hours agoThe therapy is designed to induce an antibody response against those amyloid beta versions thereby...
